SEC Form 4 · accession 0001567619-18-001851
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Henry J Fuchs
Officer — President, Worldwide R&D
Period of report
Aug 24, 2018
Accepted (ET)
Aug 28, 2018 · 5:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 24, 2018 | S | 12,500 | $99.00 | D | 142,667 | D | |
| Common Stock | Aug 27, 2018 | S | 12,500 | $100.00 | D | 130,167 | D |
Table II — derivative securities
No Table II lines on this filing.